chevron_leftBack
As of 6 June 2026, GI Innovation, Inc. has a market cap of $693.58M USD, ranking #13001 globally and #368 in South Korea.
It ranks #1182 in the Healthcare sector, and #218 in the Biotechnology industry.
Key Stats
Market Cap
$693.58MUSD
1.06T KRW
Enterprise Value
$670.99MUSD
1.03T KRW
Revenue (TTM)
$3.81MUSD
5.84B KRW
EBITDA (TTM)
-$24.56MUSD
-37.65B KRW
Net Income (TTM)
-$22.92MUSD
-35.13B KRW
PS Ratio
182.1
PB Ratio
9.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Jun Hong
open_in_new
Founded
2017
Website
gi-innovation.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.8% | 14% | 13% | 0.3% | 4.3% | 23% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
358570
GI Innovation Inc
ISIN: KR7358570000
Shares Out.:
Shares Outstanding:
64.262M1
Shares Float:
56.805M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
16,250 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About GI Innovation, Inc.
GI Innovation, Inc., a bio-venture company, engages in the research and development of protein new drugs. The company is developing GI-101/GI-102, an immune anticancer drug with novel dual fusion protein in Phase I/II clinical trial; GI-108, an metabolic immunotherapy oncology agent; and GI-301, an IgE-mediated allergy treatment designed as a fusion protein that is in Phase I clinical trial. It is also developing GI-10N, an immuno-oncology drug; GI-30N, a drug for allergic and fibrotic diseases; and GI-20N, a drug for metabolic diseases. The company was founded in 2017 and is based in Seoul, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.48B
6K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$27.89B
4K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.27B
2K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.46B
688%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.96B
471%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.23B
222%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
26K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
23K%
|
19.0
|
|
EBR: ARGX
|
$48.08B
7K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$43.01B
6K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$42.72B
6K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
4K%
|
-
|
chevron_leftBack